Default: Nanobiomedicine

ISSN:

Journal Home

Journal Guideline

Nanobiomedicine Q3 Unclaimed

SAGE Publications Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nanobiomedicine is a journal indexed in SJR in Biotechnology and Biomedical Engineering with an H index of 16. It is an CC BY-NC Journal with a Double blind peer review review system The scope of the journal is focused on nanomedicine, nanotechnology, biology, bioengineering, drug delivery, nanotoxicology. It has an SJR impact factor of 0,482 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,482.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Nanobiomedicine

0,482

SJR Impact factor

16

H Index

0

Total Docs (Last Year)

5

Total Docs (3 years)

0

Total Refs

15

Total Cites (3 years)

5

Citable Docs (3 years)

2

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


Nanomedicine Nanotechnology Biology Bioengineering Drug delivery Nanotoxicology

FAQS